Rapport Therapeutics (RAPP) Non-Current Assets (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Non-Current Assets data on file, last reported at $12.9 million in Q1 2026.

• On a quarterly basis, Non-Current Assets rose 16.39% year-over-year to $12.9 million in Q1 2026; TTM through Mar 2026 was $56.7 million, a 111.11% increase from a year earlier, with the FY2025 full-year figure at $13.9 million, up 170.32% from the prior year.
• Non-Current Assets for Q1 2026 stood at $12.9 million, down from $13.9 million in the prior quarter.
• Over the last five years, Non-Current Assets for RAPP reached as high as $15.3 million in Q2 2025 and fell as low as $4.6 million in Q4 2023.
• Historically, Non-Current Assets has averaged $9.8 million across 4 years, with a median of $11.1 million in 2025.
• Across the five-year window, Non-Current Assets increased 12.74% in 2024 and jumped 181.73% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $4.6 million in 2023, then grew by 12.74% to $5.1 million in 2024, then surged by 170.32% to $13.9 million in 2025, then fell by 6.98% to $12.9 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $12.9 million in Q1 2026, $13.9 million in Q4 2025, and $14.7 million in Q3 2025.